Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel
10.3346/jkms.2020.35.e394
- Author:
Yan JIN
1
;
Seungman CHA
;
Jinmoo LEE
;
Mousab Siddig ELHAG
;
Sung-Tae HONG
;
Young-Ha LEE
Author Information
1. Department of Microbiology, Dongguk University College of Medicine, Gyeongju, Korea
- Publication Type:Brief Communication
- From:Journal of Korean Medical Science
2020;35(46):e394-
- CountryRepublic of Korea
- Language:English
-
Abstract:
This study compared the anthelminthic effects of three different brands of praziquantel being used in Sudan against Schistosoma haematobium (S. haematobium) infection. We enrolled 1,286 schoolchildren from six primary schools and examined their urine samples for eggs of S. haematobium at the baseline survey and follow-up two weeks after administering the medication. The schoolchildren were divided into three groups based on the three brands of praziquantel (different material production), with two school children for one brand.The overall baseline prevalence of S. haematobium infection was 15.5%. Two weeks after treatment with brands A, B, and C of praziquantel, cure rates were 87.1%, 82.4% and 83.8% respectively, and the egg-reduction rates were 69.0%, 81.0% and 70.6% respectively. There was no statistically significant difference in cure rates and egg-reduction rates between the three brands. We conclude that the three different commercial brands of praziquantel used in Sudan have similar anthelminthic effects on S. haematobium.
